{ "items" : [
    { "id" : "http://dbpedia.org/resource/Ipsen"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. It is publicly traded on the Euronext Paris as part of the SBF 120 index." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Ipsen" ] ,
        "http://xmlns.com/foaf/0.1/homepage" : [ "http://www.ipsen.com" ] ,
        "http://dbpedia.org/ontology/foundingYear" : [ "1929Z" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Pharmaceutical_drug" ] ,
        "http://dbpedia.org/ontology/keyPerson" : [ "http://dbpedia.org/resource/Marc_de_Garidel" ] ,
        "http://dbpedia.org/ontology/numberOfEmployees" : [ 4900 ] ,
        "http://dbpedia.org/ontology/product" : [ "http://dbpedia.org/resource/Oncology",
          "http://dbpedia.org/resource/Cognitive_disorder",
          "http://dbpedia.org/resource/Circulatory_system",
          "http://dbpedia.org/resource/Gastroenterology",
          "http://dbpedia.org/resource/Endocrinology"] } } }
